On April 2, 2026, Keiretsu Forum’s Investor Capital Expo brought together some of the most active investors across the United States under one roof to support the spirit of innovation. They heard pitches from sixteen early-stage companies, each representing cutting-edge innovation and compelling market opportunity.
Before the day concluded, investors were asked to vote for The Most Valued Company - a distinction that defines a company’s pitch, potential, and investor interest. After a tight competition, Buoy emerged as the winner, with Precixion as the first runner-up, and Angiex Inc. and Microvascular Therapeutics sharing the honors for the second runner-up.
Let’s take a closer look at the winners, the challenges they are tackling, and their unique solution.
Buoy - The Winner
Buoy’s winning pitch centered on a startling statistic—75% of Americans are chronically dehydrated, leading to widespread health issues and reduced productivity. While hydration products are abundant, most come loaded with sugar, artificial sweeteners, or ingredients that make them unsuitable for daily use—especially for individuals managing chronic conditions.
Buoy’s answer is elegantly simple. Its Hydrating Wellness Drops are an unflavored, all-natural blend of electrolytes, vitamins, minerals, and antioxidants that can be added to any beverage. A single, palm-sized bottle delivers the electrolyte equivalent of 13 sports drinks—without the additives. With just one squeeze, any drink becomes a functional hydration solution designed for everyday use.
Founder & CEO Daniel Schindler delivered a pitch that resonated deeply with investors, combining a massive addressable market with a product that is both accessible and scalable. In a room full of strong contenders, Buoy stood out for its clarity of problem-solution fit and consumer relevance.
Precixion - The First Runner-Up
Taking the first runner-up position was Precixion, led by CEO Bala Jeldi, which is reimagining industrial manufacturing through advanced metal 3D printing.
The company addressed a critical bottleneck: aerospace, defense, and industrial sectors are grappling with casting and forging delays that can stretch up to 50 weeks. Existing additive manufacturing solutions fall short—too slow, too small, and often unable to handle complex materials.
Precixion’s AI-enabled metal 3D printer offers a step-change improvement. By integrating innovative optics with real-time quality control software, the system produces parts 5 to 10 times faster than conventional printers while ensuring production-grade quality—the result: flight-ready components delivered in weeks instead of months.
For investors, the appeal was clear—a solution targeting a deeply entrenched inefficiency in high-value supply chains.
Angiex and Microvascular Therapeutics - Joint Second Runner-Ups
The competition for second place was so close that it resulted in a tie between two biotech innovators, each tackling life-threatening challenges with novel approaches.
Angiex Inc., led by CEO Paul Jaminet, is focused on transforming cancer treatment. With cancer claiming approximately 10 million lives annually, Angiex’s approach targets both tumor growth and metastasis through TM4SF1-directed antibody-drug conjugates. By simultaneously cutting off a tumor’s blood supply and eliminating invasive cancer cells, the company is advancing toward making cancer a manageable, rather than fatal, disease.
Meanwhile, Microvascular Therapeutics, founded by Evan Unger, is redefining the role of ultrasound in medicine. Their innovation builds on microbubble technology, enhancing diagnostic imaging while opening the door to therapeutic applications. From dissolving blood clots to enabling brain tumor ablation, their platform represents a shift from ultrasound as a diagnostic tool to a potential treatment modality.
A Showcase of Innovation and Investor Conviction
While only one company could take home the top honor, the broader takeaway from Investor Capital Expo 2026 is the depth of innovation across sectors. Each of the 16 presenting companies demonstrated not just ambition, but a clear path to impact.
What ultimately set Buoy apart was its ability to connect a widespread, everyday problem to a solution that is both simple and scalable. In a room full of groundbreaking technologies, it was a reminder that sometimes the most powerful ideas fit seamlessly into daily life.
Once again, congratulations to Buoy, and kudos to the rest of the participating teams who lit up the Investor Capital Expo with their ideas. All eyes will be on June, when the Investor Capital Expo returns to showcase a new set of exciting ideas and insights.